-
"If you paint a new house, you need to scrape off the old paint, " says Rabiner.
FORBES: OmniSonics' Clot Buster
-
Rabiner, who helped launch minimally invasive surgical devices while at American Cyanamid in the early 1990s, formed the Wilmington, Mass.
FORBES: OmniSonics' Clot Buster
-
To test their technology, Rabiner and Hare used it to experimentally treat prostate enlargement, where the prostate grows and compresses the urethra.
FORBES: OmniSonics' Clot Buster
-
Rabiner says his device is much simpler to use than Possis'.
FORBES: OmniSonics' Clot Buster
-
The company has been selling its technology in Europe and Australia since 2002 for clots resulting from peripheral artery disease and dialysis, although Rabiner won't disclose sales.
FORBES: OmniSonics' Clot Buster
-
OmniSonics co-founder Robert Rabiner wants a piece of the market.
FORBES: OmniSonics' Clot Buster
-
Since only 300, 000 patients undergo surgery every year for prostate enlargement, compared with some 60 million who suffer from cardiovascular disease, Rabiner opted to pursue that market in 2000.
FORBES: OmniSonics' Clot Buster
-
Rabiner hopes to take his company public next year.
FORBES: OmniSonics' Clot Buster